Concepedia

James W. Purcell

JW

Statistics

Publications

15

Citations

758

H-Index

14

Active since

2004

Affiliations

AbbVie (United States)(Current)

Dana-Farber Cancer Institute

Harvard University

The University of Texas MD Anderson Cancer Center

Virginia Cancer Specialists

James W. Purcell is an author at AbbVie (United States) specializing in medicine, oncology, and molecular oncology.

Publications per year

2004–2022

15

Publications

15

LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates

James W. Purcell, Sonia G. Tanlimco, Jonathan A. Hickson et al. · Cancer Research · 2018 · 199 citations

Medicine, Cancer Biology, Oncology +17

M. Thomas, Clodagh Finnegan, Katherine Rogers et al. · Cancer Research · 2004 · 99 citations

Medicine, Oncology, Pharmacology +13

Activity of the Kinesin Spindle Protein Inhibitor Ispinesib (SB-715992) in Models of Breast Cancer

James W. Purcell, Mamatha Reddy, Shamra Martin et al. · Clinical Cancer Research · 2010 · 95 citations · Full text

Medicine, Cancer Biology, Pharmacology +17

First-in-Human Phase I Study of ABBV-085, an Antibody–Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors

George D. Demetri, Jason J. Luke, Antoine Hollebecque et al. · Clinical Cancer Research · 2021 · 77 citations · Full text

Medicine, Oncology, Pharmacology +17

BRCA1 Regulates IFN-γ Signaling through a Mechanism Involving the Type I IFNs

Niamh E. Buckley, Alison M. Hosey, Julia J. Gorski et al. · Molecular Cancer Research · 2007 · 51 citations

Life Sciences, Genetics, Molecular Biology +17

1–5 of 15